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To identify the possible complications after extracorporeal shock wave lithotripsy (SWL) and to suggest how to manage them,
the signiﬁcant literature concerning SWL treatment and complications was analyzed and reviewed. Complications after SWL are
mainly connected to the formation and passage of fragments, infections, the eﬀects on renal and nonrenal tissues, and the eﬀects
on kidney function. Each of these complications can be prevented adopting appropriate measures, such as the respect of the
contraindications and the recognition and the correction of concomitant diseases or infection, and using the SWL in the most
eﬃcient and safe way, tailoring the treatment to the single case. In conclusion, SWL is an eﬃcient and relatively noninvasive
treatment for urinary stones. However, as with any other type of therapy, some contraindications and potential complications do
exist. The strictness in following the ﬁrst could really limit the onset and danger of the appearance of others, which however must
be fully known so that every possible preventive measure be implemented.
1.Introduction
Since its appearance at the beginning of the 1980s [1], extra-
corporeal shock wave lithotripsy (SWL) has been conﬁrmed
as the least invasive and the most widely used treatment
of kidney and ureteral stones, also in acute conditions [2].
Naturally, like any other treatment, its eﬃcacy is indeed
accompanied by some side eﬀects and complications that,
despite being generally mild in nature, require accurate
evaluationandimplementationofmeasurestopreventthem.
An example is the ﬂank pain during the procedure, which
has not to be considered as a complication, but rather an
undesired side eﬀect to deal with very often and which can
sometimes induce the patient to ask for the interruption
of the treatment. The protocol of the procedure should so
includeananalgesicprophylaxis,andtherapywithopioidsor
nonsteroidal anti-inﬂammatory drugs were both evaluated
[3].
In essence, we are not talking about a procedure that
is altogether benign, but rather one that may bring about
lesions to kidneys and/or its neighbouring organs. Moreover,
even a technically successful lithotripsy may determine sub-
sequent morbidity due to related fragmented products. In
light of this, the few contraindications that do actually exist
should clearly be kept in mind [4]. These are:
(i) pregnancy;
(ii) uncontrolled infections in the urinary system;
(iii) uncontrolled alterations of coagulation;
(iv) aortic or renal artery aneurism;
(v) serious skeletal malformations;
(vi) serious obesity.
2. Classiﬁcation
Complications after an SWL come from:
(i) the formation and passage of fragments;
(ii) infections;
(iii) the eﬀects on renal and nonrenal tissues:2 The Scientiﬁc World Journal
(a) the eﬀects on kidney function;
(b) hypertension.
2.1. Complications Related to the Formation and Passage of
Lithiasic Fragments. The main aim of an SWL is the pulveri-
sation of stones and asymptomatic elimination of fragments.
This procedure may not always be completely successful due
to incomplete fragmentation, with residual fragments of a
signiﬁcant size, and ureteral blockage by fragments (Stein-
strasse) which ends up with an obstruction to the urinary
ﬂow.
To illustrate this, the formation of fragments <4mmis
present in up to 59% of the cases, with a risk of a symp-
tomatic episode, an operation, or even both, equal to 43%
[5].
Factors responsible for the level of fragmentation after a
lithotripsy, and therefore real risk factors for SWL failure are
the composition, volume, site, the number of stones, and the
frequency and strength of the shock wave.
2.1.1. Composition. The stones made by Struvite, uric acid,
and dehydrated calcium oxalate tend to fragment into
tiny parts that may be easily passed. On the other hand,
dehydrated calcium phosphate stones (brushite) and mono-
hydrate calcium oxalate stones tend to produce larger
fragments which are hence much harder to pass. Particularly
diﬃculttotreatarethestonesmadebycystinewhich,likeany
organic compound, has acoustic features similar to those in
the surrounding tissues.
2.1.2. Volume. The chance of SWL treatment success is
related to the volume of the stones being treated. For stones
<2cm, the percentage of success reported, considered as
“stone free rate,” has been in the range of 66–99%, which
drops to 45–70% for stones of 2-3cm and even further again
for staghorn stones [1, 6–8].
Moreover, stones >2cm almost always require multiple
treatments and have a tendency to shatter incomplete: the
risk of complication is greater with an incidence of partial
obstruction between 19–50% [8]. In some cases, it is size
alonethatdeterminestreatment:afteranSWL,cystinestones
<15mm shatter in 71% of cases; if the size of the stone is
>20mm, the success rate drops to 40% [9].
For this reason, SWL as a monotherapy for cystine stones
>15mm is currently not recommended [4].
2.1.3. Number and Site. The chances of success are less, all
other characteristics being equal, for stones located in the
lower pole of the kidney. Recorded success rates have been
in the region of 29% for stones of 11–20mm and 20% for
stones >20mm [10] that, moreover, often require multiple
treatments to be cleared up. The presence of multiple stones
hasbeentiedtoalargernumberofrelapsesafterSWL[1,11].
For ureteral stones, the percentage of overall success is not
as high in absolute terms and depends, above all, on the
segment where the stone is located: proximal ureter 82%,
medial ureter 73%, and distal ureter 74% [4].
2.1.4. Frequency and Strength of Shock Wave. Although the
eﬀects of shock wave frequency on the eﬃcacy of the treat-
ment were not clinically widely evaluated [12], in vitro stud-
ies have shown that a reduction in frequency improves the
possibility of fragmentation [13] and an increase in the volt-
age supplied is related to a reduction in lesser volume frag-
ments [14]. In addition, the energy font used was compared
to the results so, for example, an electrohydraulic lithotripsy
supplied fragments <2mm in 91% of the cases while an
electromagnetic one did so in only 65% of the cases [15].
Furthermore, success rates of 63% and 83% were recorded
for diﬀerent models of the same energy font, even if other
s t u d i e sh a v en o ta so fy e tc o n ﬁ r m e dt h i sd i ﬀerence in per-
formance [16, 17].
One complication directly related to incomplete frag-
mentation is the pileup of fragments, otherwise known as
steinstrasse. This complication appeared in 1–4% of patients,
rising to 5–10% when the stone is >2cm[18] and to 40%
where staghorn stones were present [19]. At times, the
complication resolved itself and with contained symptoma-
tology, while on other occasions recurrent colics occur. To
highlight any silent forms, the most insidious, a radiological
or ultrasound examination should be carried out routinely
4–6 weeks after the SWL treatment. Stones of >3cm should
be treated percutaneously, however, where this is impossible,
conﬁrmation of steinstrasse following an SWL is a likely
course of action and the placing of a ureteral stent may in
this case reduce the incidence of piling up of fragments.
Nevertheless, the presence of a stent does not reduce the
incidence of Steinstrasse in the case of small-to-medium-
sizedstones,andshouldthusbeavoided[18].Alsointhecase
of ureteral stones, a stent does not seem to be particularly
useful [4].
Diﬀerent options exist to deal with the problem once it
has been established. As we have already seen, in some cases,
complicationsareasymptomaticandmaysimplybefollowed
over time with spontaneous resolution of the problem in 2
to 4 weeks, always ensuring of course that renal function is
maintained [20]. Possible administration of medical treat-
ment made up of associated alpha-blockers or even corticos-
teroids [21, 22] may accelerate the clearance of fragments.
Wheresymptomsarepresentandthesteinstrasseisnolonger
than 2.5cm, it may still be a valid option to wait, that could
resolve the complication in more than a half of the patients,
naturally prescribing suitable pain control therapy.
In other cases, above all where larger distal fragments
are present, steinstrasse has eﬀectively been treated with
repeated sessions of SWL showing positive results in 90% of
cases [23]. With ureteral meatotomy results have also been
satisfactory [24]. In more serious cases, where infections and
complete obstructions are manifest, it is necessary to place
a nephrostomy or to proceed with either a retrograde or
a n t e r o g r a d ep e r c u t a n e o u su r e t e r o r e n o s c o p y .
2.2. Infective Complications. During extracorporeal lit-
hotripsy, one of the forces applied to the stone comes from
a cavitation bubble collapse. This force, however, may cause
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microhaemorrhage, the release of cell mediator of phlogosis,
and the inﬁltration by inﬂammatory response cells.
These tiny lesions may also allow the passage of bacteria,
which may be present in the urine or inside the stones
themselves, into the blood stream which could thus develop
into other related problems.
To simplify things here, we will deﬁne “infection” as
a harmful colonization of a species unknown to the host
organism that responds to the infection with inﬂammation.
By the term “sepsis,” on the other hand, we refer instead to
a serious medical condition characterised by a generalised
state of inﬂammation, called SIRS (systematic inﬂammatory
response syndrome), and by the deﬁnite or suspected pres-
ence of an infection [25]. Evidence of bacteriuria is present
in up to 23.5% of patients [26], while a real clinical urinary
infection is more frequently observed in patients with
either multiple or complex struvite stones [27].
The development of sepsis after bacteremia is relatively
low in absolute terms, <1% of cases [26], although it is
considerably higher in the presence of staghorn stones [8].
The risk of infection is naturally greater, where urinoculture
is positive or where urinary obstruction exists.
There are no truly trustworthy signs that attest to the
early onset of bacteremia or bacteriuria: white cells blood
count, speed of erythrosedimentation, and a positive culture
are all useful signs, unfortunately they generally tend to
show up positive when the patient is already symptomatic.
In terms of reduction of infective complications and the
expense connected to their treatment, the use of antibiotic
prophylaxis has thereforebeen proposed, butthis use has not
been conﬁrmed in other randomised controlled studies for
patients without preexisting UTI or infected stones [28].
To sum up then, antibiotics should only be administered
to patients with positive urine culture, with staghorn or low
density struvite stones, with a history of struvite stones or
recurring urinary infections, to patients who will undergo a
contemporary instrumental procedure, and ﬁnally to those
with a nephrostomy or a stent in place [27, 28].
2.3. Eﬀects on Tissues
2.3.1.Kidney. Themostevidentexpressionofkidneytrauma
is haematuria that generally passes in a few days.
Collections of symptomatic ﬂuids or perirenal, subcap-
sular, or intrarenal haematomas are rare and occur in less
than 1% of patients; if, however, patients have systematically
undergone a CT scan or MRI then evidence of haematoma
rises to 25% [29]. Other lesions show in X-rays in most
patients: an increase in the volume in the kidney [30] ,al o s s
in corticomedullary demarcations [30] ,a n dar e d u c t i o ni n
thesignalintheperirenalfat.Thesesignsexpresslesionssuch
as haemorrhages, generally focalised, and oedema within
and around the kidney [31]. Perirenal collections typically
disappear after a few days, while a period of between 6 weeks
and 6 months is required for subcapsular ones [32]. It is rare
to see lesions for any longer than that.
A microscopic examination shows up characteristic evi-
dences: haemorrhagic lesions are preferentially localised in
the corticomedullar joint, probably due to diﬀerences in the
density of the tissue at that level [33]; moreover, signs of
damage are immediately visible from the thin vascular walls
andtheglomeruli[34].Haemorrhageleadstotissuehypoxia,
which can play a role in the development of apoptosis,
but it has been experimentally shown that shock waves
administration does not aﬀect the apoptosis index in normal
ratsafter2000and4000shockwaves[35]andafter1-2weeks
signs of reorganisation may be noticed, while after 1 month
signs of glomerular atrophy and sclerosis are noticeable in
tiny areas of ﬁbrosis. However, most of the parenchyma
appears normal [32], leading to the conclusion that damage
due to SWL is a focal process that leaves most of the
parenchyma intact. A short pretreatment with 10–20 shock-
waves could further on reduce the renal tissue damage,
probably due to a reﬂex local vasoconstriction.
2.3.2. Cardiovascular Apparatus. The incidence of arrhyth-
mia during an SWL varies from between 11% and 59%, and
is, in general, related to minor premature ventricular beats.
Evidence of ischemic lesions is very rare, and this incidence
may be further reduced by synchronising the supply of
shock waves with pulsations [36]. There is no documented
relationship between the onset of arrhythmia and age,
sex, cardiopathy, site, volume of the stone, onsite stent or
nephrostomy, with or without anaesthesia, the number of
shock waves, and the type of lithotripter [36]. Even those
patients with pace makers may undergo an SWL with
necessary precautions and cardiological supervision [37].
Although clinical and experimental data indicates that pa-
tients with aortic or renal aneurisms may be treated success-
fully, literature has reported some cases of breakage after an
SWL [38]. It is clear, as in other similar cases, that a careful
examination of the cost/beneﬁt relationship is necessary
and that where the procedure is embarked upon each and
every possible development must be considered beforehand.
Cases of serious venous thrombosis after SWL have also
been recorded, the exact pathogenesis of which is still badly
deﬁned; however, it is probably caused by haematological
disorders, even if this may just be to a small extent [39].
The association between SWL and arterial hypertension
has always been a controversial argument and debated. The
diagnosis of hypertension after SWL has been reported in
8% of cases, that does not diﬀer greatly however from
the incidence of about 6% of new diagnosis in the overall
population [40]. An increase in diastolic pressure after an
SWL was also noted, and a relationship between this and
the number of shock waves was therefore hypothesised upon
[41].
Al a r g er e t r o s p e c t i v es t u d yh a sa n a l y s e dp a t i e n t sw h o
underwent an SWL, controlled against patients who under-
went an ureterorenoscopy or a percutaneous lithotripsy
without being able to show, within one year of the treatment,
any signiﬁcant diﬀerences in the incidence of hypertension
(2.4% versus 4%), andevenafter 4years,the diﬀerences were
not particularly signiﬁcant (2.1% versus 1.6%); however, a
statistically signiﬁcant increase in diastolic pressure showed
upafterSWL[42].Ther ealcausesofh ypert ensionaft erSWL
a r em o r el i k e l yt oh a v em a n yd i ﬀerent factors, and there is
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between hypertension and the procedure even if one con-
siders more recent studies that have demonstrated, with a
followupof24months,howitisthepresenceofstonesrather
than the modality of treatment that determines the increase
in pressure [43].
Many of the studies that have been documented are ret-
rospective. Limiting oneself to randomly controlled studies
there is no evidence that SWL treatment determines changes
in arterial pressure [40, 44]; in fact, it is possible that the
extracorporeallithotripsyisresponsibleforhypotension,and
likewise for alterations in renal metabolism determined by
the treatment and function of the number and strength of
shock waves administered [45].
2.3.3. Gastrointestinal Apparatus. Several gastrointestinal
lesions of various types have repeatedly been recorded fol-
lowing an SWL with a global incidence of 1.8% [46]. A spe-
ciﬁc study has shown gastroduodenal erosions in 80% of pa-
tients who underwent a pre- and post-SWL endoscopic
study [47]. The exact mechanism of the lesions is, as of yet,
unknown, however, the majority were observed in patients
subjected to treatment in prone position and in patients who
had undergone a number of shock waves that exceeds what is
recommended [46].
2.3.4. Fertility and Pregnancy. As u ﬃciently high amount
of clinical and experimental evidence exists to exclude any
permanent eﬀects on testicular or ovarian function to thus
conﬁrm that there are no existing correlations between SWL
and fertility [48, 49]. Pregnancy, however, constitutes an
absolute contraindication to the procedure itself because of
any potentially harmful eﬀects to the foetus from shock
waves, as has repeatedly been shown in the results of many
experimental studies [50].
3. Conclusions
Extracorporeal lithotripsy is an eﬃcient and relatively non-
invasive treatment for urinary stones: the large number of
cases treated using this procedure, and its widespread use,
testiﬁes to this. However, as with any other type of therapy
somecontraindicationsandpotentialcomplicationsdoexist.
The strictness in following the ﬁrst could really limit the
onsetanddangeroftheappearanceofothers,whichhowever
must be fully known in order that every possible preventive
measure be implemented.
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